Serivan Tablet

Introduction

Serivan Tablet 17 mg is an atypical antipsychotic medication used primarily for the treatment of Parkinson's disease psychosis. It is distinct from other antipsychotics in that it is a selective serotonin inverse agonist rather than a dopamine antagonist. This unique mechanism makes it useful for managing hallucinations and delusions in Parkinson's disease without worsening motor symptoms.

Uses

Serivan Tablet 17 mg is mainly used for:

Managing Parkinson's disease psychosis, including hallucinations and delusions.
It is prescribed when psychotic symptoms occur in patients with Parkinson's disease who are not adequately managed with other treatments.

Brand Name	Serivan
Type	Tablet
Weight	17 mg
Generic	Pimavanserin
Manufacturer	Incepta Pharmaceuticals Ltd.
Available in	English বাংলা

Mechanism of Action

Serivan Tablet 17 mg works by selectively binding to and acting as an inverse agonist at serotonin 5-HT2A receptors. Unlike traditional antipsychotics that block dopamine receptors, Serivan Tablet 17 mg specifically targets serotonin receptors to modulate neurotransmission, which helps reduce psychotic symptoms without impacting dopamine pathways, thus preserving motor function.

How Long Does It Take to Work?

Patients may start to notice improvements in psychotic symptoms within 1 to 2 weeks of starting Serivan Tablet 17 mg, though the full therapeutic effects might take up to 4 to 6 weeks to become apparent.

Absorption

Serivan Tablet 17 mg is well-absorbed after oral administration. It reaches peak plasma concentrations within 3 to 4 hours. Food intake does not significantly affect its absorption, so it can be taken with or without food.

Route of Elimination

Serivan Tablet 17 mg is primarily metabolized in the liver, mainly by the cytochrome P450 enzyme system (particularly CYP3A4). Its metabolites are then excreted through the feces, with a minor portion eliminated in the urine.

Dosage

The recommended dosage of Serivan Tablet 17 mg for treating Parkinson's disease psychosis is:

34 mg taken orally once daily.

Dosage adjustments are not typically required unless there are significant interactions with other medications.

Administration

Serivan Tablet 17 mg should be administered orally, with or without food. It is typically taken once daily, and adherence to the prescribed dosage schedule is crucial for optimal therapeutic effects.

Side Effects

Common side effects of Serivan Tablet 17 mg include:

Peripheral edema
Confusion
Falls
Nausea

Rare but serious side effects may include:

QT prolongation
Severe allergic reactions

Toxicity

In cases of overdose, symptoms may include severe dizziness, drowsiness, or confusion. There is no specific antidote for Serivan Tablet 17 mg overdose; supportive care and symptomatic treatment are recommended.

Precautions

Serivan Tablet 17 mg should be used with caution in patients with hepatic impairment due to its metabolism by the liver. Regular monitoring of liver function may be necessary. It should also be used cautiously in patients with a history of cardiovascular issues or prolonged QT interval.

Interaction

Interactions with other medications, particularly those affecting CYP3A4, can alter Serivan Tablet 17 mg levels. It is important to review all concurrent medications and consult healthcare providers to manage potential interactions.

Disease Interaction

Patients with hepatic impairment or a history of cardiovascular conditions should be carefully monitored while on Serivan Tablet 17 mg. The drug’s effects on liver function and cardiovascular health necessitate close observation.

Drug Interaction

Potential drug interactions include:

Strong CYP3A4 inhibitors (e.g., ketoconazole) which may increase Serivan Tablet 17 mg levels.
Strong CYP3A4 inducers (e.g., rifampin) which may decrease Serivan Tablet 17 mg levels.

Adjustments to dosage may be required based on these interactions.

Food Interactions

Food does not significantly impact the absorption of Serivan Tablet 17 mg. It can be taken with or without food according to patient preference.

Pregnancy Use

The safety of Serivan Tablet 17 mg during pregnancy has not been well established. It should be used during pregnancy only if the potential benefits justify the potential risks to the fetus. Consult a healthcare provider for a risk-benefit assessment.

Lactation Use

It is not known whether Serivan Tablet 17 mg is excreted in human milk. Caution is advised when administering Serivan Tablet 17 mg to breastfeeding mothers, and a decision should be made whether to discontinue breastfeeding or to discontinue the medication.

Acute Overdose

In the event of an acute overdose, symptomatic and supportive care should be provided. There is no specific antidote for Serivan Tablet 17 mg, so monitoring and supportive measures are essential.

Contraindication

Serivan Tablet 17 mg is contraindicated in individuals with known hypersensitivity to the drug or its components. Caution is also advised in those with significant liver impairment.

Use Direction

Follow the prescribed dosing instructions and take Serivan Tablet 17 mg exactly as directed. It is important to adhere to the daily dosing schedule for effective management of Parkinson's disease psychosis.

Storage Conditions

Serivan Tablet 17 mg should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.

Volume of Distribution

The volume of distribution of Serivan Tablet 17 mg is approximately 90 liters, indicating extensive distribution throughout the body.

Half Life

The elimination half-life of Serivan Tablet 17 mg is about 18 hours, allowing for once-daily dosing to maintain therapeutic levels in the body.

Clearance

Serivan Tablet 17 mg clearance is primarily hepatic, with a substantial amount of the drug metabolized by the liver. Its clearance rate can be influenced by liver function and interactions with other medications.

See in details version Serivan Tablet 17 mg also Serivan Tablet 17 mg in bangla